Bacterial Infections  >>  MenAfriVac (meningococcal A conjugate vaccine)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MenAfriVac (meningococcal A conjugate vaccine) / Serum Institute of India
NCT01303211: A Case-control Study of the Efficacy of a New Serogroup A Meningococcal Conjugate Vaccine (MenAfriVac) in Mali and Niger

Withdrawn
N/A
0
RoW
London School of Hygiene and Tropical Medicine, Bill and Melinda Gates Foundation
Meningococcal Disease
05/13
11/13

Download Options